Avoid common mistakes on your manuscript.
Correction to: Breast Cancer Research and Treatment https://doi.org/10.1007/s10549-020-05750-y
In the original publication of the article, under the Results section, subheading “Patient survival”, the second sentence that reads as “The 6-month PFS was 92.4%, 81.8%, and 93.3% and the 1-year PFS was 72.0%, 88.9%, and 78.9% in Groups 1–3, respectively.” should read as "The 6-month PFS was 82.8%, 75.0%, and 68.0% and the 1-year PFS was 77.0%, 62.0%, and 63.8% in Groups 1–3, respectively.".
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ham, A., Kim, M.H., Kim, G.M. et al. Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer. Breast Cancer Res Treat 183, 493 (2020). https://doi.org/10.1007/s10549-020-05796-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-020-05796-y